Tackling the Bottlenecks in the Drug Development Pipeline directorsblog.nih.gov
Can you believe the average length of time from target discovery to approval of a new drug currently averages about 14 years? That is WAY too long. Even more shocking is that the failure rate exceeds 95 percent, and the cost...